Not surprisingly, HuNb1-IgG4 shows better efficacy of anti-ovarian tumor and anti-lymphoma compared to anti-CD47 Hu5F9-G4 monoclonal antibody at the same doses. Here, CD47 is linked to ovarian neoplasm.